Table of Content


Introduction
Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Overview
Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Therapeutics Development
Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Therapeutics Assessment
Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Companies Involved in Therapeutics Development
Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Drug Profiles
Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Dormant Products
Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Discontinued Products
Cytotoxic T Lymphocyte Protein 4 (Cytotoxic T Lymphocyte Associated Antigen 4 or CD152 or CTLA4) - Product Development Milestones
Appendix



List of Figures


Number of Products under Development by Stage of Development, H2 2019
Number of Products under Development by Therapy Areas, H2 2019
Number of Products under Development by Top 10 Indications, H2 2019
Number of Products by Mechanism of Actions, H2 2019
Number of Products by Stage and Mechanism of Actions, H2 2019
Number of Products by Routes of Administration, H2 2019
Number of Products by Stage and Routes of Administration, H2 2019
Number of Products by Top 10 Molecule Types, H2 2019
Number of Products by Stage and Top 10 Molecule Types, H2 2019


List of Tables


Number of Products under Development by Stage of Development, H2 2019
Number of Products under Development by Therapy Areas, H2 2019
Number of Products under Development by Indications, H2 2019
Number of Products under Development by Indications, H2 2019 (Contd..1), H2 2019
Number of Products under Development by Indications, H2 2019 (Contd..2), H2 2019
Number of Products under Development by Indications, H2 2019 (Contd..3), H2 2019
Number of Products under Development by Indications, H2 2019 (Contd..4), H2 2019
Number of Products under Development by Indications, H2 2019 (Contd..5), H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Companies, H2 2019 (Contd..1)
Number of Products under Development by Companies, H2 2019 (Contd..2)
Products under Development by Companies, H2 2019
Products under Development by Companies, H2 2019 (Contd..1), H2 2019
Products under Development by Companies, H2 2019 (Contd..2), H2 2019
Products under Development by Companies, H2 2019 (Contd..3), H2 2019
Products under Development by Companies, H2 2019 (Contd..4), H2 2019
Products under Development by Companies, H2 2019 (Contd..5), H2 2019
Products under Development by Companies, H2 2019 (Contd..6), H2 2019
Products under Development by Companies, H2 2019 (Contd..7), H2 2019
Products under Development by Companies, H2 2019 (Contd..8), H2 2019
Products under Development by Companies, H2 2019 (Contd..9), H2 2019
Products under Development by Companies, H2 2019 (Contd..10), H2 2019
Products under Development by Companies, H2 2019 (Contd..11), H2 2019
Products under Development by Companies, H2 2019 (Contd..12), H2 2019
Products under Development by Companies, H2 2019 (Contd..13), H2 2019
Products under Development by Companies, H2 2019 (Contd..14), H2 2019
Products under Development by Companies, H2 2019 (Contd..15), H2 2019
Products under Development by Companies, H2 2019 (Contd..16), H2 2019
Products under Development by Companies, H2 2019 (Contd..17), H2 2019
Products under Development by Companies, H2 2019 (Contd..18), H2 2019
Products under Development by Companies, H2 2019 (Contd..19), H2 2019
Products under Development by Companies, H2 2019 (Contd..20), H2 2019
Products under Development by Companies, H2 2019 (Contd..21), H2 2019
Products under Development by Companies, H2 2019 (Contd..22), H2 2019
Number of Products under Investigation by Universities/Institutes, H2 2019
Products under Investigation by Universities/Institutes, H2 2019
Number of Products by Stage and Mechanism of Actions, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Pipeline by Abeome Corp, H2 2019
Pipeline by Aduro BioTech Inc, H2 2019
Pipeline by Agenus Inc, H2 2019
Pipeline by Akeso Biopharma Inc, H2 2019
Pipeline by Alligator Bioscience AB, H2 2019
Pipeline by AlphaMab Co Ltd, H2 2019
Pipeline by Alpine Immune Sciences Inc, H2 2019
Pipeline by Anaeropharma Science Inc, H2 2019
Pipeline by Apollomics Inc, H2 2019
Pipeline by AstraZeneca Plc, H2 2019
Pipeline by BeyondSpring Inc, H2 2019
Pipeline by Biocad, H2 2019
Pipeline by Biosortia Pharmaceuticals, H2 2019
Pipeline by BJ Bioscience Inc, H2 2019
Pipeline by Bristol-Myers Squibb Co, H2 2019
Pipeline by Cancure Ltd, H2 2019
Pipeline by Cellective BioTherapy Inc, H2 2019
Pipeline by Cold Genesys Inc, H2 2019
Pipeline by CStone Pharmaceuticals Co Ltd, H2 2019
Pipeline by DotBio Pte Ltd, H2 2019
Pipeline by Five Prime Therapeutics Inc, H2 2019
Pipeline by GigaGen Inc, H2 2019
Pipeline by Harbour BioMed, H2 2019
Pipeline by Hengenix Biotech Inc, H2 2019
Pipeline by Hualan Biological Engineering Inc, H2 2019
Pipeline by Immunocore Ltd, H2 2019
Pipeline by Immunwork Inc, H2 2019
Pipeline by Immutics Inc, H2 2019
Pipeline by Innovent Biologics Inc, H2 2019
Pipeline by Inovio Pharmaceuticals Inc, H2 2019
Pipeline by JHL Biotech Inc, H2 2019
Pipeline by Jiangsu Alphamab Biopharmaceuticals Co Ltd, H2 2019
Pipeline by MacroGenics Inc, H2 2019
Pipeline by Merck & Co Inc, H2 2019
Pipeline by Momenta Pharmaceuticals Inc, H2 2019
Pipeline by Nanjing Jinsirui Biotechnology Co Ltd, H2 2019
Pipeline by OncoImmune Inc, H2 2019
Pipeline by Premier Biomedical Inc, H2 2019
Pipeline by Regeneron Pharmaceuticals Inc, H2 2019
Pipeline by Replimune Ltd, H2 2019
Pipeline by Serometrix LLC, H2 2019
Pipeline by Shanghai Henlius Biotech Inc, H2 2019
Pipeline by Shanghai Junshi Bioscience Co Ltd, H2 2019
Pipeline by Shanghai Mab Venture Biopharm Co Ltd, H2 2019
Pipeline by Sorrento Therapeutics Inc, H2 2019
Pipeline by Sound Biologics, H2 2019
Pipeline by Stcube Inc, H2 2019
Pipeline by Tikcro Technologies Ltd, H2 2019
Pipeline by Xencor Inc, H2 2019
Dormant Products, H2 2019
Dormant Products, H2 2019 (Contd..1), H2 2019
Dormant Products, H2 2019 (Contd..2), H2 2019
Discontinued Products, H2 2019
Discontinued Products, H2 2019 (Contd..1), H2 2019